Literature DB >> 12426262

Structural changes of the airway wall impair respiratory function, even in mild asthma.

Kumiko Shiba1, Keita Kasahara, Hiroaki Nakajima, Mitsuru Adachi.   

Abstract

STUDY
OBJECTIVES: To clarify whether structural changes of the airway wall impair respiratory function in patients with mild asthma, and to determine whether mild asthma should be treated with inhaled steroids.
SETTING: Showa University Hospital in Tokyo. PATIENTS: Thirteen healthy nonatopic volunteers (control subjects), 26 patients with mild asthma treated with a bronchodilator alone without oral or inhaled corticosteroids or antiallergic agents, and 10 patients with mild-to-moderate asthma treated with inhaled corticosteroids. MEASUREMENTS: We measured the thickness of the epithelial reticular basement membrane (Rbm) of the airway wall in bronchial biopsy specimens from patients with asthma and from healthy control subjects. We also performed spirometry and histamine challenge tests to evaluate airflow obstruction and airway hyperresponsiveness.
RESULTS: The thickness of the Rbm in patients with mild asthma was significantly greater than that in healthy control subjects and was negatively correlated with the FEV(1) as a percentage of FVC and the provocative concentration of histamine that caused a 20% decrease in FEV(1) from the post-saline solution baseline value. Moreover, the Rbm was thicker in patients with mild asthma not treated with inhaled steroids than in patients with mild-to-moderate asthma treated with inhaled steroids.
CONCLUSIONS: The thickness of the Rbm is increased even in mild asthma and is correlated with airway obstruction and hyperresponsiveness. Our results suggests that anti-inflammatory treatment with inhaled steroids should be started in the early stage of bronchial asthma to prevent structural changes from occurring in the airway wall.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426262     DOI: 10.1378/chest.122.5.1622

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Asthma therapy and its effect on airway remodelling.

Authors:  Rachid Berair; Christopher E Brightling
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

2.  Corticosteroids and montelukast: effects on airway epithelial and human umbilical vein endothelial cells.

Authors:  K Andersson; E B Shebani; N Makeeva; G M Roomans; Z Servetnyk
Journal:  Lung       Date:  2010-01-16       Impact factor: 2.584

3.  Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.

Authors:  G Feljandro P Ramos; Sandra Kuiper; Edward Dompeling; Antoinette D I van Asselt; Wim J C de Grauw; J André Knottnerus; Onno C P van Schayck; Tjard R J Schermer; Johan L Severens
Journal:  BMC Med Res Methodol       Date:  2011-11-09       Impact factor: 4.615

4.  Bronchial hyper-responsiveness, subepithelial fibrosis, and transforming growth factor-beta(1) expression in patients with long-standing and recently diagnosed asthma.

Authors:  Aneta Tomkowicz; Maria Kraus-Filarska; Julia Bar; Jerzy Rabczyński; Michał Jeleń; Paweł Piesiak; Andrzej Fal; Bernard Panaszek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-12-01       Impact factor: 4.291

5.  Reticular basement membrane in asthma and COPD: similar thickness, yet different composition.

Authors:  Jeroen J W Liesker; Nick H Ten Hacken; Mieke Zeinstra-Smith; Steven R Rutgers; Dirkje S Postma; Wim Timens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.